 |
|
|
ImenVax (TM) Immuno-Therapeutic Cancer Treatment
for Canines
In the encapsulated ImenVax™ device, a “cocktail” of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient’s immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1) |
|
Entest BioMedical, Inc. • 4700 Spring Street, Suite 203 • La Mesa, CA • 91942 • Phone:
(619) 644-3344 • Fax: (619) 330-2328
|
